BC Extra | Sep 26, 2018
Company News

Management tracks: Merck clears path for Frazier to remain CEO

The board of Merck & Co. Inc. (NYSE:MRK) rescinded a 28-year-old policy that required CEOs to retire at age 65. CEO Kenneth Frazier, who turns 65 in December 2019, has agreed to stay in his...
BC Week In Review | Mar 2, 2015
Financial News

Dance Biopharm completes venture financing

Dance Biopharm Inc. , Brisbane, Calif.   Business: Endocrine/Metabolic   Date completed: 2015-02-18   Type: Venture financing   Raised: $9.5 million   Placement agent: SternAegis Ventures   Investors: Individual investors; institutional investors   Note: The offering...
BC Week In Review | Oct 20, 2014
Financial News

Dance Biopharm withdraws IPO

Dance Biopharm Inc. , Brisbane, Calif.   Business: Endocrine/Metabolic   Date announced: 2014-10-15   Type: IPO   Underwriters: Wells Fargo; Stifel, Nicolaus & Co.; Oppenheimer; Roth Capital Partners   Note: The company withdrew its proposed IPO...
BC Extra | Oct 17, 2014
Financial News

Dance withdraws IPO

Dance Biopharm Inc. (Brisbane, Calif.) withdrew its proposed IPO on NASDAQ. The diabetes company did not provide a reason in its SEC filing. In April, the company filed to raise up to $75 million in...
BioCentury | Oct 6, 2014
Finance

4Q14 Financial Markets Preview: 'Perfect world' - for now

Even as the major biotech indices creep toward new all-time highs, buysiders are hard-pressed to identify any major risks that could cause a downturn in the fourth quarter. At the same time, there are few...
BioCentury | Jul 14, 2014
Finance

3Q14 Financial Markets Preview: Discerning optimism

Investors and bankers are cautiously optimistic that the correction that began in late 1Q14 will provide a floor for a biotech recovery that should continue through the third quarter, with investors being more selective on...
BC Week In Review | Apr 14, 2014
Financial News

Dance Biopharm proposes IPO

Dance Biopharm Inc. , Brisbane, Calif.   Business: Endocrine/Metabolic   Date announced: 4/9/14   Type: IPO   To be raised: Up to $75 million   Shares: TBD   Price: TBD   Underwriters: Wells Fargo; Stifel, Nicolaus;...
BC Extra | Apr 10, 2014
Financial News

Inhalable insulin play Dance files for IPO

Dance Biopharm Inc. (Brisbane, Calif.) filed to raise up to $75 million in an IPO on NASDAQ underwritten by Wells Fargo; Stifel; Oppenheimer; and Roth Capital Partners. Dance is developing Dance 501 (formerly Adagio ),...
BC Week In Review | Oct 21, 2013
Company News

Dance Biopharm, Harmony Asset deal

Dance and Harmony formed a JV to develop and commercialize Dance's Adagio inhaled insulin in China and other Asian countries, excluding Japan. Harmony, which will have majority ownership of the JV, will be responsible for...
BC Week In Review | Aug 19, 2013
Clinical News

Adagio: Phase I/II data

Preliminary data from the Phase I/II Samba 01 trial in 12 Type I diabetics showed that Adagio was safe and well tolerated and did not lead to coughing. Dance Biopharm said Adagio delivered insulin consistently...
Items per page:
1 - 10 of 10
BC Extra | Sep 26, 2018
Company News

Management tracks: Merck clears path for Frazier to remain CEO

The board of Merck & Co. Inc. (NYSE:MRK) rescinded a 28-year-old policy that required CEOs to retire at age 65. CEO Kenneth Frazier, who turns 65 in December 2019, has agreed to stay in his...
BC Week In Review | Mar 2, 2015
Financial News

Dance Biopharm completes venture financing

Dance Biopharm Inc. , Brisbane, Calif.   Business: Endocrine/Metabolic   Date completed: 2015-02-18   Type: Venture financing   Raised: $9.5 million   Placement agent: SternAegis Ventures   Investors: Individual investors; institutional investors   Note: The offering...
BC Week In Review | Oct 20, 2014
Financial News

Dance Biopharm withdraws IPO

Dance Biopharm Inc. , Brisbane, Calif.   Business: Endocrine/Metabolic   Date announced: 2014-10-15   Type: IPO   Underwriters: Wells Fargo; Stifel, Nicolaus & Co.; Oppenheimer; Roth Capital Partners   Note: The company withdrew its proposed IPO...
BC Extra | Oct 17, 2014
Financial News

Dance withdraws IPO

Dance Biopharm Inc. (Brisbane, Calif.) withdrew its proposed IPO on NASDAQ. The diabetes company did not provide a reason in its SEC filing. In April, the company filed to raise up to $75 million in...
BioCentury | Oct 6, 2014
Finance

4Q14 Financial Markets Preview: 'Perfect world' - for now

Even as the major biotech indices creep toward new all-time highs, buysiders are hard-pressed to identify any major risks that could cause a downturn in the fourth quarter. At the same time, there are few...
BioCentury | Jul 14, 2014
Finance

3Q14 Financial Markets Preview: Discerning optimism

Investors and bankers are cautiously optimistic that the correction that began in late 1Q14 will provide a floor for a biotech recovery that should continue through the third quarter, with investors being more selective on...
BC Week In Review | Apr 14, 2014
Financial News

Dance Biopharm proposes IPO

Dance Biopharm Inc. , Brisbane, Calif.   Business: Endocrine/Metabolic   Date announced: 4/9/14   Type: IPO   To be raised: Up to $75 million   Shares: TBD   Price: TBD   Underwriters: Wells Fargo; Stifel, Nicolaus;...
BC Extra | Apr 10, 2014
Financial News

Inhalable insulin play Dance files for IPO

Dance Biopharm Inc. (Brisbane, Calif.) filed to raise up to $75 million in an IPO on NASDAQ underwritten by Wells Fargo; Stifel; Oppenheimer; and Roth Capital Partners. Dance is developing Dance 501 (formerly Adagio ),...
BC Week In Review | Oct 21, 2013
Company News

Dance Biopharm, Harmony Asset deal

Dance and Harmony formed a JV to develop and commercialize Dance's Adagio inhaled insulin in China and other Asian countries, excluding Japan. Harmony, which will have majority ownership of the JV, will be responsible for...
BC Week In Review | Aug 19, 2013
Clinical News

Adagio: Phase I/II data

Preliminary data from the Phase I/II Samba 01 trial in 12 Type I diabetics showed that Adagio was safe and well tolerated and did not lead to coughing. Dance Biopharm said Adagio delivered insulin consistently...
Items per page:
1 - 10 of 10